Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Amy Chan

Showing results (91-100 of 111) with videos related to

Pageof 12
Sort By:
World Journal of Surgery|January 25, 2012
Early data from the first population-wide breast cancer-specific registry in Hong KongPolly Cheung, W K Hung, Catherine Cheung, et al.
Journal of Medicinal Chemistry|February 3, 2025
Expanding Conjugate Space of RNAi Therapeutics: Ligand at the 3' End of the Antisense Strand Achieves Uncompromised In Vivo Potency and Efficacy and Reveals Interactions with the Argonaute-2 PAZ DomainRajat S Das, Dhrubajyoti Datta, Christopher R Brown, et al.
The Journal of Urology|June 24, 2026
Oncological Outcomes of Non-Muscle Invasive Bladder Cancer in Patients Aged ≤45: A Retrospective Matched Cohort StudyMarie-Pier St-Laurent, Shayan Din, Joseph Moryousef, et al.
International Journal of Geriatric Psychiatry|May 19, 2025
Prevalence of Dementia in European, Chinese and Indian/Fijian-Indian Populations in Aotearoa New Zealand: A ProtocolSarah Cullum, Xiaojing Wu, Claudia Rivera-Rodriguez, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|October 10, 2017
Evaluation of GalNAc-siRNA Conjugate Activity in Pre-clinical Animal Models with Reduced Asialoglycoprotein Receptor ExpressionJennifer L S Willoughby, Amy Chan, Alfica Sehgal, et al.
BJU International|December 18, 2023
Long-term outcomes and cost savings of office fulguration of papillary Ta low-grade bladder cancerChristian Vitug, Katherine Lajkosz, Julian Chavarriaga, et al.
The New England Journal of Medicine|February 7, 2019
Phase 1 Trial of an RNA Interference Therapy for Acute Intermittent PorphyriaEliane Sardh, Pauline Harper, Manisha Balwani, et al.
BJU International|November 19, 2025
Risk of metachronous upper tract urothelial carcinoma following non-muscle-invasive bladder cancerKeiran J C Pace, Jethro C C Kwong, Harkanwal Randhawa, et al.
Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis|April 2, 2016
Preclinical evaluation of RNAi as a treatment for transthyretin-mediated amyloidosisJames S Butler, Amy Chan, Susete Costelha, et al.
Journal of Medicinal Chemistry|February 9, 2023
Metabolically Stable Anomeric Linkages Containing GalNAc-siRNA Conjugates: An Interplay among ASGPR, Glycosidase, and RISC PathwaysPachamuthu Kandasamy, Shohei Mori, Shigeo Matsuda, et al.
Pageof 12

Showing results (91-100 of 111) with videos related to

Sort By:
Pageof 12
World Journal of Surgery|January 25, 2012
Early data from the first population-wide breast cancer-specific registry in Hong KongPolly Cheung, W K Hung, Catherine Cheung, et al.
Journal of Medicinal Chemistry|February 3, 2025
Expanding Conjugate Space of RNAi Therapeutics: Ligand at the 3' End of the Antisense Strand Achieves Uncompromised In Vivo Potency and Efficacy and Reveals Interactions with the Argonaute-2 PAZ DomainRajat S Das, Dhrubajyoti Datta, Christopher R Brown, et al.
The Journal of Urology|June 24, 2026
Oncological Outcomes of Non-Muscle Invasive Bladder Cancer in Patients Aged ≤45: A Retrospective Matched Cohort StudyMarie-Pier St-Laurent, Shayan Din, Joseph Moryousef, et al.
International Journal of Geriatric Psychiatry|May 19, 2025
Prevalence of Dementia in European, Chinese and Indian/Fijian-Indian Populations in Aotearoa New Zealand: A ProtocolSarah Cullum, Xiaojing Wu, Claudia Rivera-Rodriguez, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|October 10, 2017
Evaluation of GalNAc-siRNA Conjugate Activity in Pre-clinical Animal Models with Reduced Asialoglycoprotein Receptor ExpressionJennifer L S Willoughby, Amy Chan, Alfica Sehgal, et al.
BJU International|December 18, 2023
Long-term outcomes and cost savings of office fulguration of papillary Ta low-grade bladder cancerChristian Vitug, Katherine Lajkosz, Julian Chavarriaga, et al.
The New England Journal of Medicine|February 7, 2019
Phase 1 Trial of an RNA Interference Therapy for Acute Intermittent PorphyriaEliane Sardh, Pauline Harper, Manisha Balwani, et al.
BJU International|November 19, 2025
Risk of metachronous upper tract urothelial carcinoma following non-muscle-invasive bladder cancerKeiran J C Pace, Jethro C C Kwong, Harkanwal Randhawa, et al.
Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis|April 2, 2016
Preclinical evaluation of RNAi as a treatment for transthyretin-mediated amyloidosisJames S Butler, Amy Chan, Susete Costelha, et al.
Journal of Medicinal Chemistry|February 9, 2023
Metabolically Stable Anomeric Linkages Containing GalNAc-siRNA Conjugates: An Interplay among ASGPR, Glycosidase, and RISC PathwaysPachamuthu Kandasamy, Shohei Mori, Shigeo Matsuda, et al.
Pageof 12